Week of October 4, 2022 | Vol. 11, Issue 39

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners
October 12, 2022 - Charlotte, NC
October 24-26, 2022 - Leipzig, Germany
November 1-3, 2022 - Messe Frankfurt, Germany
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
M&A TRANSACTIONS

Pharma & Biotech

11 transactions totaling $1,333 million


Supplies, Equipment & Services

15 transactions totaling $1,438 million


Healthcare IT & Managed Care

6 transactions



Healthcare Facilities & Distributors

2 transactions totaling $1 million

PRIVATE PLACEMENTS

Pharma & Biotech

32 transactions totaling $548 million


Supplies, Equipment & Services

17 transactions totaling $199 million


Healthcare IT & Managed Care

15 transactions totaling $219 million


Healthcare Facilities & Distributors

3 transactions

PUBLIC OFFERINGS

Pharma & Biotech

12 transactions totaling $371 million


Supplies, Equipment & Services

2 transactions totaling $92 million


Healthcare IT & Managed Care

0 transactions 


Healthcare Facilities & Distributors

3 transactions totaling $25 million

TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.






MARKET REPORTS
Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Consumer Health Sector Snapshot Q2 2022

June 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Ester

Sell-side |Pharma| OTC Technology and Products Developer


Project Gateway

Sell-Side |Pharma| Generic Pharmaceuticals


Project Jazz

Sell-Side |Pharma Services| Compounding Pharmacy and Pharmacy Service Provider

Project Panther

Sell-Side| CDMO | Consumer Health and Medical Device


Project Power Play

Buy-Side | Specialty Pharma |Branded & Generic Pharmaceuticals


Project Trident

Buy-Side | Generic Pharma | Manufacturing liquid generics

FEATURED HEADLINES

A Sampling of Industry Headlines

ConcertAI, LSU Health New Orleans team up to tackle clinical trial diversity

Fierce Biotech - September 28, 2022

iuvo BioScience to be Acquired by Ampersand Capital Partners

Ampersand Capital Partners - September 28, 2022

BioIVT continues spending spree with acquisition of biospecimen collection network Fidelis Research

Fierce Biotech - September 28, 2022

Emmes Acquires Clinical Edge

PR Newswire - September 28, 2022

Societal CDMO Announces Signing of Multiple Agreements With New and Existing Customers

Societal CDMO - September 29, 2022

TANNER NEWS

Linkedin  

Rare Diseases 2022 Campaign

The #RareDiseases2022 campaign is a collaboration of the global rare disease community to raise awareness and share ideas. Find Tanner's article printed inside The Guardian or read it online on page 8, with insights from EVP John Lagus on alternate ways for rare disease patients to access treatment. 

Overcoming Procurement and Supply Chain Challenges in Clinical Trials

The global pandemic has had a significant impact on clinical trials, forcing operators to alter their processes. Discover how TannerCTS is helping partners overcome these new challenges and ensure supply continuity from EVP of Clinical Services, Georg Schulz.

Let's Connect!
The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.